Clinical Trial Update: Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing sugammadex (MK-8616) in elderly versus adult participants to assess efficacy, safety, and pharmacokinetics in general anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia-related Care

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED | Results posted: 2019-03-25